Endocrinology

Endocrinology

Osteoporosis is a progressive bone disease causing decreased bone density and increased fracture risk. IV bisphosphonate infusion therapy can prevent further bone loss and reduce fractures.

Overview

Osteoporosis is a progressive bone disease characterized by decreased bone density and strength, making bones more fragile and susceptible to fractures. It develops silently over many years, often without symptoms until a fracture occurs. It is most common in postmenopausal women due to hormonal changes, but also affects men and younger individuals. While osteoporosis cannot be fully reversed, infusion-based treatments can help prevent further bone loss and significantly reduce fracture risk.

Symptoms

  • Fractures from minimal trauma — especially of the spine, hip, or wrist
  • Back pain from vertebral fractures or collapse
  • Loss of height over time
  • Stooped or hunched posture (kyphosis)
  • Often asymptomatic until a fracture occurs

When to See a Doctor

Consult a doctor for unexplained fractures after minimal trauma, persistent severe back pain, or a noticeable decrease in height. Seek immediate care for severe back pain after a fall or difficulty walking from a possible hip fracture.

Causes

  • Hormonal changes: decreased estrogen after menopause or testosterone in men
  • Nutritional deficiencies in calcium or vitamin D
  • Genetic predisposition — family history of osteoporosis
  • Sedentary lifestyle, smoking, and excessive alcohol use
  • Long-term corticosteroid use or other bone-affecting medications
  • Coexisting conditions like rheumatoid arthritis or hyperthyroidism

Risk Factors

  • Age over 50
  • Female sex — especially postmenopausal women
  • Family history of osteoporosis or fractures
  • Small body frame or low body weight
  • Nutritional deficiencies in calcium and vitamin D
  • Physical inactivity
  • Chronic conditions affecting bone metabolism

Complications

  • Increased fracture risk — particularly spinal, hip, and wrist
  • Chronic pain and reduced mobility
  • Loss of height and postural changes (kyphosis)
  • Decreased independence and quality of life
  • Emotional and psychological challenges

Treatment Considerations

Bisphosphonate infusions and other IV bone therapies offer an effective alternative for patients who cannot tolerate daily oral medications. Infusion therapy allows for annual or quarterly dosing with clinical monitoring, improving adherence and reducing the gastrointestinal side effects associated with oral regimens.

Commonly Used Medications

Prolia, Reclast

Ready to Start Treatment?

Start Your Treatment